| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Krystal Biotech, Inc. (KRYS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 94 sells. KRYS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.50M | $444.98M | - | |
| Pres | 1.43M | $423.61M | - | |
| Dir | 75.7K | $22.45M | - | |
| Dir | 5.0K | $1.48M | - | |
| Dir | 5.0K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Krishnan Krish S46 | President And CEO | Sell | 25,000 | $263.17 | $6,579,164.34 | -0.2% | - | - | |
| Mar 4, 2026 | Krishnan Suma46 | President, R&D | Sell | 25,000 | $263.21 | $6,580,270.41 | -0.2% | - | - | |
| Feb 27, 2026 | Janney Daniel | Director | Sell | 11,803 | $275.59 | $3,252,824.35 | -7.3% | - | - | |
| Dec 4, 2025 | Krishnan Krish S46 | President And CEO | Sell | 50,000 | $220.15 | $11,007,446.72 | -0.2% | +19.4% | - | |
| Dec 4, 2025 | Krishnan Suma46 | President, R&D | Sell | 50,000 | $220.15 | $11,007,332.86 | -0.2% | +19.4% | - | |
| Jul 16, 2025 | Krishnan Suma46 | President, R&D | Sell | 35,873 | $150.39 | $5,395,000.82 | -0.3% | +25.3% | - | |
| Jul 16, 2025 | Krishnan Krish S46 | President And CEO | Sell | 35,873 | $150.39 | $5,395,000.82 | -0.3% | +25.3% | - | |
| Jul 10, 2025 | Krishnan Suma46 | President, R&D | Sell | 14,127 | $150.27 | $2,122,834.96 | -0.2% | +25.0% | - | |
| Jul 10, 2025 | Krishnan Krish S46 | President And CEO | Sell | 14,127 | $150.27 | $2,122,834.96 | -0.2% | +25.0% | - | |
| Mar 13, 2025 | Krishnan Suma46 | President, R&D | Sell | 50,000 | $177.79 | $8,889,524.59 | -0.3% | -21.3% | +39.4% |